Litcius/Paper detail

Tacrolimus- versus sirolimus-based immunosuppression after simultaneous pancreas and kidney transplantation: 5-year results of a randomized trial

Diego Cantarovich, Delphine Kervella, Georges Karam, Jacques Dantal, Gilles Blancho, Magali Giral, Claire F. Garandeau, Aurélie Houzet, Simon Ville, Julien Branchereau, Florent Delbos, Cécile Guillot-Gueguen, Christelle Volteau, Maxime Leroy, Karine Renaudin, Jean‐Paul Soulillou, Maryvonne Hourmant

2020American Journal of Transplantation21 citationsDOIOpen Access PDF

Topics & Concepts

MedicineTacrolimusSirolimusImmunosuppressionUrologyKidney transplantationTransplantationSurgeryInterim analysisProtein synthesis inhibitorDiscontinuationClinical endpointRandomized controlled trialRegimenGastroenterologyInternal medicineAntibacterial agentAntibioticsMicrobiologyBiologyRenal Transplantation Outcomes and TreatmentsOrgan Transplantation Techniques and OutcomesAdenosine and Purinergic Signaling
Tacrolimus- versus sirolimus-based immunosuppression after simultaneous pancreas and kidney transplantation: 5-year results of a randomized trial | Litcius